High levels of DNA excision repair (ERCC1) protein [82], mutations or down-regulation of MLH1, MSH2 and MSH1 [83], and secondary mutations of BRCA1/2 genes [84] have been shown to be involved in platinum-resistant ovarian cancer development. This evidence concerns the gene BRCA1 and ovarian carcinoma.